UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 29, 2022 (
(Exact name of registrant as specified in its charter) |
|
| |||
(State of other jurisdiction |
| (Commission |
| (IRS Employer |
of incorporation) |
| File Number) |
| Identification No.) |
(Address of principal executive office)
(
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
|
|
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12) | |
|
|
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b)) | |
|
|
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company.
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 7.01 Regulation FD Disclosure.
On July 29, 2022, Know Labs, Inc. (the “Company”) filed with the Securities and Exchange Commission a registration statement on Form S-1 under the Securities Act of 1933, as amended. The prospectus within the registration statement contains a four-page presentation with updated information about the Company’s products in development. A copy of the four-page presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. |
| Description |
|
|
|
|
| - 2 - |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Registrant: KNOW LABS, INC. | |||
| By: | /s/ Ronald P. Erickson | ||
| Ronald P. Erickson | ||
Chairman of the Board | |||
July 29, 2022
| - 3 - |
EXHIBIT 99.1
KnowU™️ Product Design The KnowU system is in development and designed to easily fit in a customer’s pocket. The Know Labs product development team is miniaturizing the lab based system for field testing and commercialization. The KnowU will be wireless and able to conduct measurements in the field with ease via a companion App. This is a 3D printed prototype of the KnowU for internal testing. Results presented above reflect internal Company testing and might not be replicated in the future as a result of various factors not in our control. You are cautioned not to place undue reliance on the utility of the information provided as a predictor of future performance of the Company’s products in development. Risks related to our product development are discussed elsewhere in this prospectus.
| 1 |
KnowU Glucose Results vs Dexcom® G6 Measuring Glucose in the body is the core focus of Know Labs. Using the latest version of Hardware and Software, the team is building a Gold-Master Glucose dataset. These tests directly compare the Know Labs sensor to the Dexcom G6. The Dexcom G6 was chosen as the reference device because is the industry leader in CGM accuracy. The tests are 3 hours long and collect Know Labs sensor data on 2,500 frequencies. These tests create a high value Glucose data asset, which is essential for R&D and algorithm development. July 2022 internal test results demonstrate that the Know Labs sensor has equivalent correlation to the Dexcom G6. Test method: Participant rests arm on Know Labs sensor for 3 hours, while wearing a Dexcom G6. 30 minutes in, the participant drinks 35 mg fast acting glucose. Know Labs sensor data (Pink line) is compared directly to Dexcom G6 data (Orange line). Glucose Level 3 hours KnowU Signal Results presented above reflect internal Company testing and might not be replicated in the future as a result of various factors not in our control. You are cautioned not to place undue reliance on the utility of the information provided as a predictor of future performance of the Company’s products in development. Risks related to our product development are discussed elsewhere in this prospectus.
| 2 |
System Test: Measuring Oxygen in the Body The Know Labs sensor and system is designed to measure many different analytes in the body. Measuring Oxygen is the standard hardware/software system test. Over the last 4 years, the team has conducted over 2,400 Oxygen tests and the technology is now performing equivalent to a gold standard, medical grade, SpO2 sensor. Oxygen tests are repeatable, reliable, and successful across a diverse set of participants. The graphs below are tests conducted with the Know Labs sensor. Oxygen % Oxygen % 5 minutes 5 minutes Test method: Breathe normally for 100 seconds, hold breath for 20 seconds, resume normal breathing. Graph 1 is sensing the oxygen levels through the left arm. Graph 2 is sensing the oxygen levels through the right arm. Same biological event. Results presented above reflect internal Company testing and might not be replicated in the future as a result of various factors not in our control. You are cautioned not to place undue reliance on the utility of the information provided as a predictor of future performance of the Company’s products in development. Risks related to our product development are discussed elsewhere in this prospectus.
| 3 |
Multiple Locations on the Body The Know Labs sensor is designed to work on multiple locations on the body, in any form factor. To demonstrate this capability, the Know Labs team conducted the standard Oxygen system test on 11 different locations on the body. The sensor performed with accurate and reliable results in every testing location. Test method: Breathe normally for 100 seconds, hold breath for 20 seconds, resume normal breathing. Graph 1 is sensing the oxygen levels through the left arm. Graph 2 is sensing the oxygen levels through the right arm. Same biological event. Results presented above reflect internal Company testing and might not be replicated in the future as a result of various factors not in our control. You are cautioned not to place undue reliance on the utility of the information provided as a predictor of future performance of the Company’s products in development. Risks related to our product development are discussed elsewhere in this prospectus.
| 4 |